[The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)]

Urol Nefrol (Mosk). 1995 Mar-Apr;(2):46-7.
[Article in Russian]

Abstract

Oral administration of Rhodiola rosea extract to a small group of patents (n = 12) with superficial bladder carcinoma (T1G1-2) improved the characteristics of the urothelial tissue integration, parameters of leukocyte integrins and T-cell immunity. The average frequency of relapses for these patients has been found to fall twice, though statistical differences were not significant.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / epidemiology
  • Carcinoma, Transitional Cell / immunology
  • Carcinoma, Transitional Cell / pathology
  • Drug Evaluation
  • Humans
  • Immunity / drug effects
  • Incidence
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / immunology
  • Neoplasm Recurrence, Local / pathology
  • Plant Extracts / therapeutic use*
  • Time Factors
  • Urinary Bladder / drug effects
  • Urinary Bladder / pathology
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / epidemiology
  • Urinary Bladder Neoplasms / immunology
  • Urinary Bladder Neoplasms / pathology

Substances

  • Plant Extracts